Recent extremely meaningful positive changes in fundamentals have benefitted ICU Medical Inc (NASDAQ: ICUI): the consensus estimate for December, 2024 increased significantly, the stock’s power rating rose above 70, the consensus estimate for December, 2025 increased significantly, and significant quarterly earnings acceleration occurred.
In light of these very positive signals we are reviewing our current Overall Rating of B. We would continue to view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
ICUI is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
ICU Medical has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. ICU Medical has a neutral Appreciation Score of 50 but a good Power Rating of 82, triggering the Positive Value Trend Rating.
Recent Price Action
On 9/3/24, ICU Medical Inc (NASDAQ: ICUI) stock declined modestly by -1.4%, closing at $163.09. However, trading volume in this decline was below average at 75% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but is unchanged during the last week.
Be the first to comment